mucin1-aptamer functionalized miRNA-29b-loaded hybrid nanoparticles (Thomas Jefferson)

N/A

Report date: 2025/03/20 15:30:44

NME

Base Information

Drug Namemucin1-aptamer functionalized miRNA-29b-loaded hybrid nanoparticles (Thomas Jefferson)

Drug Alias NameMAFMILHNs (Thomas Jefferson)microRNA-29b

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer

Mechanisms of ActionMucin-1 modulators

TargetsMucin-1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThomas Jefferson University

China Registration ClassN/A

Develop Information

Active CompaniesThomas Jefferson University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A